Galata LATA Stock Risk Reward Ratio 020 20260418 NAGE Niagen Bioscience Inc reports solid Q4 2025 EPS beat and nearly 30 percent year over year revenue growth stock rises modestly APLD Applied Digital Corporation shares climb 479 percent despite far wider than expected Q1 2026 per share losses Is HIVE HIVE stock trading below fair range Q1 2026 Earnings Fall Short AGNCP Q1 2026 Earnings Preferred Shares Benefit as EPS Exceeds Estimates by 145 PIII Q1 2026 Earnings Massive EPS Beat Drives Surprise Profitability Yet Stock Declines TG Therapeutics Q1 2026 Earnings EPS Disappoints as Stock Declines WM Q1 2026 Earnings EPS Beat Provides Support Amid Broader Market Decline IMCC Q1 2026 Earnings Widening Loss Amid Unreported Revenue Highlights Persistent Challenges ATAT Q1 2026 Earnings EPS Surges Past Estimates Stock Declines Despite Strong Beat